Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy

Hamdy N El-Tallawy,1 Sawsan Abuhamdah,2,3 Ahmed Y Nassar,4 Wafaa MA Farghaly,1 Tahia H Saleem,4 Sara A Atta,4 Ayat A Sayed,4 Amal M Tohamy,1 Mohammed H Hassan5 1Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University, Assiut, Egypt; 2Department of Pharmaceutical Sciences, Coll...

Full description

Bibliographic Details
Main Authors: El-Tallawy HN, Abuhamdah S, Nassar AY, Farghaly WMA, Saleem TH, Atta SA, Sayed AA, Tohamy AM, Hassan MH
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
pharmacoresistant epilepsy
rs928553t/c
rs12782374g/a
real time-pcr
Online Access:https://www.dovepress.com/gephyrin-and-cyp2c9-genetic-polymorphisms-in-patients-with-pharmacores-peer-reviewed-fulltext-article-PGPM

Internet

https://www.dovepress.com/gephyrin-and-cyp2c9-genetic-polymorphisms-in-patients-with-pharmacores-peer-reviewed-fulltext-article-PGPM

Similar Items